Arcoma

Arcoma Pre-Tax Margin

The Pre-Tax Profit Margin of Arcoma (ARCOMA.ST) as of Oct 24, 2026 is 4.82 %. In the previous year, Pre-Tax Profit Margin was 8.78 % — a change of -45.09% (lower).

Pre-Tax Margin

4.82 %

YoY

-45.09%

Last updated:

Pre-Tax Profit Margin of Arcoma is 2025 4.82 % . Pre-Tax Profit Margin of Arcoma was 2024 8.78 % . It decreases by -45.09% lower compared to the previous year.

The Arcoma Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2018
-0.74 SEK
Jan 1, 2019
6.65 SEK
Jan 1, 2020
1.49 SEK
Jan 1, 2021
-7.61 SEK
Jan 1, 2022
1.70 SEK
Jan 1, 2023
1.92 SEK
Jan 1, 2024
8.78 SEK
Jan 1, 2025
4.82 SEK
The Arcoma Pre-Tax Margin history
YEARPre-Tax MarginYoY
4.82 %-45.09%
8.78 %+356.85%
1.92 %+13.31%
1.70 %-122.29%
-7.61 %-611.20%
1.49 %-77.62%
6.65 %-997.79%
-0.74 %-93.83%
-12.01 %-8.69%
-13.15 %+115.64%
-6.10 %+166.88%
-2.28 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Pre-Tax Profit Margin of Arcoma is 4.82 % in 2025.

Pre-Tax Profit Margin of Arcoma changed from 8.78 % to 4.82 %, representing a -45.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Arcoma since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Arcoma with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Arcoma

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Arcoma